These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 33482346

  • 21. Novel precision therapies for cholangiocarcinoma: an overview of clinical trials.
    Uson Junior PLS, Bearss J, Babiker HM, Borad MJ.
    Expert Opin Investig Drugs; 2023 Jan; 32(1):69-75. PubMed ID: 36714945
    [Abstract] [Full Text] [Related]

  • 22. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
    Demols A, Maréchal R, Devière J, Van Laethem JL.
    Best Pract Res Clin Gastroenterol; 2007 Jan; 21(6):1015-29. PubMed ID: 18070701
    [Abstract] [Full Text] [Related]

  • 23. The state of therapy modalities in clinic for biliary tract cancer.
    Chen W, Hu Z, Song J, Wu Y, Zhang B, Zhang L.
    Front Biosci (Landmark Ed); 2022 Jun 08; 27(6):185. PubMed ID: 35748261
    [Abstract] [Full Text] [Related]

  • 24. [Diagnosis and treatment of cholangiocarcinoma].
    Korean J Hepatol; 2005 Jun 08; 11 Suppl 1():48-58. PubMed ID: 23570223
    [No Abstract] [Full Text] [Related]

  • 25. [Molecular profiling in daily practice for cholangiocarcinoma].
    Selves J.
    Ann Pathol; 2022 Dec 08; 42(6S):6S5-6S7. PubMed ID: 36577541
    [No Abstract] [Full Text] [Related]

  • 26. Update on cholangiocarcinoma: potential impact of genomic studies on clinical management.
    Walter D, Hartmann S, Waidmann O.
    Z Gastroenterol; 2017 Jun 08; 55(6):575-581. PubMed ID: 28376540
    [Abstract] [Full Text] [Related]

  • 27. Cholangiocarcinoma.
    Ahrendt SA, Nakeeb A, Pitt HA.
    Clin Liver Dis; 2001 Feb 08; 5(1):191-218. PubMed ID: 11218916
    [Abstract] [Full Text] [Related]

  • 28. Targeted therapies in advanced biliary tract cancers-a narrative review.
    LaPelusa M, Heumann T, Goff L, Agarwal R.
    Chin Clin Oncol; 2023 Apr 08; 12(2):14. PubMed ID: 36946186
    [Abstract] [Full Text] [Related]

  • 29. Advances in the diagnosis, evaluation and management of cholangiocarcinoma.
    Singh P, Patel T.
    Curr Opin Gastroenterol; 2006 May 08; 22(3):294-9. PubMed ID: 16550045
    [Abstract] [Full Text] [Related]

  • 30. FGFR2 Inhibition in Cholangiocarcinoma.
    Vogel A, Segatto O, Stenzinger A, Saborowski A.
    Annu Rev Med; 2023 Jan 27; 74():293-306. PubMed ID: 36170665
    [Abstract] [Full Text] [Related]

  • 31. Precision approaches for cholangiocarcinoma: progress in clinical trials and beyond.
    Uson Junior PLS, Borad MJ.
    Expert Opin Investig Drugs; 2022 Jan 27; 31(1):125-131. PubMed ID: 34904492
    [Abstract] [Full Text] [Related]

  • 32. Genetic and molecular abnormalities in cholangiocarcinogenesis.
    Hassid VJ, Orlando FA, Awad ZT, Tan D, Khoury T, Ahmed BH, Alrawi SJ.
    Anticancer Res; 2009 Apr 27; 29(4):1151-6. PubMed ID: 19414358
    [Abstract] [Full Text] [Related]

  • 33. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma?
    Slattery JM, Sahani DV.
    Oncologist; 2006 Sep 27; 11(8):913-22. PubMed ID: 16951395
    [Abstract] [Full Text] [Related]

  • 34. [Medical management of cholangiocarcinoma].
    Barrioz T.
    Gastroenterol Clin Biol; 2004 Jan 27; 28(1):57-65. PubMed ID: 15041812
    [No Abstract] [Full Text] [Related]

  • 35. Immunotherapy in Biliary Tract Cancers: Where Are We?
    Kalyan A, Khosla H, Kim RD.
    Curr Oncol Rep; 2022 Dec 27; 24(12):1821-1828. PubMed ID: 36192517
    [Abstract] [Full Text] [Related]

  • 36. [Management of hilar cholangiocarcinoma].
    Muscari F.
    J Chir (Paris); 2007 Dec 27; 144(5):385-92. PubMed ID: 18065892
    [Abstract] [Full Text] [Related]

  • 37. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.
    Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM, Gores GJ.
    J Hepatol; 2014 Jun 27; 60(6):1268-89. PubMed ID: 24681130
    [No Abstract] [Full Text] [Related]

  • 38. The role of endoscopy in the evaluation and treatment of patients with biliary neoplasia.
    American Society for Gastrointestinal Endoscopy (ASGE) Standards of Practice Committee, Anderson MA, Appalaneni V, Ben-Menachem T, Decker GA, Early DS, Evans JA, Fanelli RD, Fisher DA, Fisher LR, Fukami N, Hwang JH, Ikenberry SO, Jain R, Jue TL, Khan K, Krinsky ML, Malpas PM, Maple JT, Sharaf RN, Shergill AK, Dominitz JA, Cash BD.
    Gastrointest Endosc; 2013 Feb 27; 77(2):167-74. PubMed ID: 23219047
    [No Abstract] [Full Text] [Related]

  • 39. Gene alterations and epigenetic changes in intrahepatic cholangiocarcinoma.
    Huang SB, Zheng CX.
    Expert Rev Anticancer Ther; 2017 Jan 27; 17(1):89-96. PubMed ID: 27893290
    [Abstract] [Full Text] [Related]

  • 40. [Cholangiocarcinoma].
    Schmielau J, Klempnauer J, Schmiegel W.
    Internist (Berl); 1997 Oct 27; 38(10):970-6. PubMed ID: 9432505
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.